Education
About Us
Working with TipRanks
Follow Us
Inoviq Ltd (AU:IIQ)
ASX:IIQ
IIQ Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.35 - AU$0.80
Previous CloseN/A
Volume76.26K
Average Volume (3M)50.97K
Market Cap
AU$42.98M
Enterprise ValueAU$42.83M
Total Cash (Recent Filing)AU$7.56M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding111,632,805
10 Day Avg. Volume47,341
30 Day Avg. Volume50,969
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)133.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Inoviq Ltd News
PremiumCompany Announcements
Inoviq Ltd Issues Unquoted Equity Securities to Employees
PremiumCompany Announcements
Inoviq Ltd Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Inoviq Ltd Announces Proposed Issue of Securities
PremiumCompany Announcements
INOVIQ Unveils CAR-Exosome Therapeutic Program in Investor Briefing
PremiumCompany Announcements
INOVIQ’s neuCA15-3 Test Shows Superior Breast Cancer Detection
PremiumCompany Announcements
Inoviq Ltd Sees Change in Substantial Shareholder StatusPremiumCompany Announcements
INOVIQ CEO to Present at ShareCafe Small Cap Webinar---
Options Prices
Currently, No data available
---
Ownership Overview
6.10% Insiders
―
Mutual Funds
― Other Institutional Investors
93.90% Public Companies and
Individual Investors
IIQ FAQ
What was Inoviq Ltd’s price range in the past 12 months?
Inoviq Ltd lowest share price was AU$0.34 and its highest was AU$0.80 in the past 12 months.
What is Inoviq Ltd’s market cap?
Inoviq Ltd’s market cap is AU$42.98M.
When is Inoviq Ltd’s upcoming earnings report date?
Inoviq Ltd’s upcoming earnings report date is Sep 02, 2025 which is in 129 days.
How were Inoviq Ltd’s earnings last quarter?
Inoviq Ltd released its earnings results on Feb 20, 2025. The company reported -AU$0.033 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.033.
Is Inoviq Ltd overvalued?
According to Wall Street analysts Inoviq Ltd’s price is currently Overvalued.
Does Inoviq Ltd pay dividends?
Inoviq Ltd does not currently pay dividends.
What is Inoviq Ltd’s EPS estimate?
Inoviq Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Inoviq Ltd have?
Inoviq Ltd has 111,632,805 shares outstanding.
What happened to Inoviq Ltd’s price movement after its last earnings report?
Inoviq Ltd reported an EPS of -AU$0.033 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Inoviq Ltd?
Currently, no hedge funds are holding shares in AU:IIQ
---
Inoviq Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IIQ Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$87.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.03%
12-Months-Change
Fundamentals
Return on Equity
-39.07%
Trailing 12-Months
Asset Growth
15.05%
Trailing 12-Months
Company Description
Inoviq Ltd
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.
---
Technical Analysis
Biotron Limited
―
Imugene Limited
―
Patrys Limited
―
Proteomics International Laboratories Ltd.
―
Recce Pharmaceuticals Ltd.
―
---